MED

$12.590.48%0.06

Dopo l'orario di chiusura: 12.590.00 0.00%

Medifast Inc (MED)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$12.53

Aprire:

$12.61

Volume 24 ore:

123,784

Volume relativo:

0.76

Capitalizzazione di mercato:

$140.79M

Reddito:

$346.10M

Utile/perdita netta:

-$20.02M

Rapporto P/E:

EPS:

-$1.82

Flusso di cassa netto:

-$1.47M

1W Prestazione:

+0.80%

1M Prestazione:

+7.33%

6M Prestazione:

+15.40%

1Y Prestazione:

+5.98%

Intervallo 1D:

$12.51$12.85

Intervallo di 1 settimana:

$12.00$12.85

Portata 52W:

$9.22$13.45

Profilo aziendale di Medifast Inc (MED)

Nome

Medifast Inc

Settore

Consumer Cyclical

Industria

Personal Services

Telefono

(410) 581-8042

Indirizzo

1501 S. CLINTON STREET, BALTIMORE, MD, USA

Dipendente

380

@optavia_tweets

Prossima data di guadagno

null

Ultimi documenti SEC

SEC

Discussioni di MED su X

Cap. di mercato

Reddito

Reddito netto

Flusso di cassa

EPS

Medifast Inc Azioni (MED) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2024-11-05	Aggiornamento	DA Davidson	Underperform → Neutral
2024-06-05	Downgrade	DA Davidson	Neutral → Underperform
2023-10-13	Iniziato	Stephens	Equal-Weight
2022-11-04	Downgrade	DA Davidson	Buy → Neutral
2022-08-04	Downgrade	Jefferies	Buy → Hold
2021-01-25	Aggiornamento	Jefferies	Hold → Buy
2020-11-05	Aggiornamento	DA Davidson	Neutral → Buy
2020-06-25	Iniziato	B. Riley FBR	Buy
2020-02-27	Downgrade	Jefferies	Buy → Hold
2019-11-08	Downgrade	Dougherty & Company	Buy → Neutral
2019-07-25	Iniziato	Jefferies	Buy
2018-11-08	Aggiornamento	Sidoti	Neutral → Buy
2018-03-07	Aggiornamento	Sidoti	Neutral → Buy
2017-09-15	Reiterato	DA Davidson	Buy
2016-08-04	Reiterato	Wunderlich	Hold
2016-01-11	Aggiornamento	Sidoti	Neutral → Buy
2015-11-30	Downgrade	Sidoti	Buy → Neutral
2015-10-05	Aggiornamento	Sidoti	Neutral → Buy
2014-11-07	Downgrade	Imperial Capital	Outperform → In-line
2014-08-08	Reiterato	Imperial Capital	Outperform
2014-04-23	Reiterato	Imperial Capital	Outperform
2013-09-06	Iniziato	Imperial Capital	Outperform
2012-11-06	Reiterato	Northland Securities	Outperform
2012-07-27	Aggiornamento	Northland Securities	Market Perform → Outperform
2012-07-09	Downgrade	Standpoint Research	Buy → Hold
2012-01-30	Iniziato	Standpoint Research	Buy

Medifast Inc Azioni (MED) Dati Finanziari

Periodo	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Data di fine periodo	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	385.79	602.46	1,072.05	1,598.58	1,526.09
Cost of revenue USD (M)	110.60	157.84	296.20	458.16	398.49
Gross profit USD (M)	275.19	444.62	775.85	1,140.41	1,127.60
Research and development USD (M)	4.30	4.60	4.60	4.50	4.40
Operating expenses USD (M)	-	-	649.45	955.61	911.36
Operating income USD (M)	-14.21	2.88	126.40	184.81	216.24
Income before tax USD (M)	-5.64	3.79	128.80	184.06	216.13
Income tax expense USD (M)	13.03	1.70	29.38	40.49	52.10
Net income USD (M)	-18.67	2.09	99.42	143.57	164.03
Basic EPS USD/shares	-1.70	0.19	9.13	12.82	14.01
Diluted EPS USD/shares	-1.70	0.19	9.10	12.73	13.89
Basic weighted shares shares (M)	10.98	10.93	10.88	11.20	11.71
Diluted weighted shares shares (M)	10.98	10.96	10.92	11.28	11.81
Selling, general and administrative USD (M)	289.40	441.75	649.45	955.61	911.36

Medifast Inc Azioni (MED) insider trading

Kiai ParsaOct 28 '26
Director
Transazione
Buy
Costo
$12.24
#Azioni
5,557
Valore ($)
68,027
#Azioni Totale
712,891
Chard Daniel RSep 29 '26
Officer
Transazione
Proposed Sale
Costo
$11.73
#Azioni
9,544
Valore ($)
111,951
#Azioni Totale
0
Chard Daniel RSep 29 '26
Director
Transazione
Sale
Costo
$11.73
#Azioni
9,544
Valore ($)
111,951
#Azioni Totale
130,609
Chard Daniel RSep 28 '26
Officer
Transazione
Proposed Sale
Costo
$11.98
#Azioni
9,545
Valore ($)
114,338
#Azioni Totale
0
Chard Daniel RSep 28 '26
Director
Transazione
Sale
Costo
$11.98
#Azioni
9,545
Valore ($)
114,338
#Azioni Totale
140,153
Kiai ParsaAug 26 '26
Director
Transazione
Buy
Costo
$12.26
#Azioni
43,150
Valore ($)
529,157
#Azioni Totale
707,492
Kiai ParsaAug 24 '26
Director
Transazione
Buy
Costo
$12.00
#Azioni
4,329
Valore ($)
51,946
#Azioni Totale
665,517
Kiai ParsaAug 20 '26
Director
Transazione
Buy
Costo
$11.60
#Azioni
43,150
Valore ($)
500,700
#Azioni Totale
661,306
Kiai ParsaAug 19 '26
Director
Transazione
Buy
Costo
$11.66
#Azioni
29,337
Valore ($)
341,999
#Azioni Totale
619,331
SCHLACKMAN SCOTTMay 11 '26
Director
Transazione
Buy
Costo
$12.53
#Azioni
2,500
Valore ($)
31,325
#Azioni Totale
30,549

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Kiai Parsa	Director	Oct 28 '26	Buy	$12.24	5,557	68,027	712,891
Chard Daniel R	Officer	Sep 29 '26	Proposed Sale	$11.73	9,544	111,951	0
Chard Daniel R	Director	Sep 29 '26	Sale	$11.73	9,544	111,951	130,609
Chard Daniel R	Officer	Sep 28 '26	Proposed Sale	$11.98	9,545	114,338	0
Chard Daniel R	Director	Sep 28 '26	Sale	$11.98	9,545	114,338	140,153
Kiai Parsa	Director	Aug 26 '26	Buy	$12.26	43,150	529,157	707,492
Kiai Parsa	Director	Aug 24 '26	Buy	$12.00	4,329	51,946	665,517
Kiai Parsa	Director	Aug 20 '26	Buy	$11.60	43,150	500,700	661,306
Kiai Parsa	Director	Aug 19 '26	Buy	$11.66	29,337	341,999	619,331
SCHLACKMAN SCOTT	Director	May 11 '26	Buy	$12.53	2,500	31,325	30,549

Medifast Inc Borsa (MED) Ultime notizie

Oct 28, 2026

5 insightful analyst questions from Medifast’s Q3 earnings call - Yahoo Finance

Oct 28, 2026

Medifast Is Running The Same Playbook, And I Have The Same Concerns (NYSE:MED) - Seeking Alpha

Oct 28, 2026

Oct 27, 2026

Medifast Q3 Loss Narrower Than Expected as Coach Productivity Rises - Zacks Investment Research

Oct 27, 2026

Medifast Q3 Loss Narrower Than Expected as Coach Productivity Rises - TradingView

Oct 27, 2026

Form 144 MEDIFAST INC For: 27 October By Investing.com - Investing.com Nigeria

Oct 27, 2026

Form 144 MEDIFAST INC For: 27 October By Investing.com - Investing.com UK

Oct 27, 2026

Medifast Inc (MED) (Q3 2026) Earnings Call Highlights: Revenue Stabilizes Near $75 Million as ... - Yahoo Finance

Oct 27, 2026

Oct 26, 2026

Medifast, Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:MED) 2026-10-26 - Seeking Alpha

Oct 26, 2026

Medifast Inc reports results for the quarter ended September 30 - Earnings Summary - TradingView

Oct 26, 2026

Medifast Q3 2026 Earnings Call Transcript - Benzinga

Oct 26, 2026

Medifast: Q3 Earnings Snapshot - KTVB

Oct 26, 2026

Medifast Reports $72 Million in Q3 Revenue and $17.5 Million Net Loss - TradingView

Oct 26, 2026

Medifast Announces Third Quarter 2026 Financial Results - Business Wire

Oct 26, 2026

Oct 23, 2026

Medifast Q3 Earnings on the Horizon: Key Insights for Investors - Zacks Investment Research

Oct 23, 2026

Medifast Q3 Earnings on the Horizon: Key Insights for Investors - Yahoo Finance

Oct 23, 2026

Oct 20, 2026

Zacks upgrades Medifast stock to Strong Buy ahead of October 26 results - AD HOC NEWS

Oct 20, 2026

Oct 15, 2026

Medifast (NYSE:MED) Short Interest Falls: What Does the Shift Reveal? - Kalkine Media

Oct 15, 2026

Medifast Inc (NYSE:MED) Sees Significant Decrease in Short Interest - MarketBeat

Oct 15, 2026

Oct 14, 2026

Quarterly results are scheduled before markets open Oct. 26, with Medifast's call at 8:30 a.m. - Stock Titan

Oct 14, 2026

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2026 - Business Wire

Oct 14, 2026

Best Momentum Stocks to Buy for October 14th - Zacks Investment Research

Oct 14, 2026

New Strong Buy Stocks for October 14th - Zacks Investment Research

Oct 14, 2026

Oct 13, 2026

Can Hormel Foods Keep Expanding Margins Despite Softer Retail Volumes? - Zacks Investment Research

Oct 13, 2026

Medifast (NYSE:MED) Shares Break Above 200-Day Moving Average - What's Next? - MarketBeat

Oct 13, 2026

Oct 08, 2026

Medifast presented Trilivy data and Medifast stock costs EUR 10.16 - AD HOC NEWS

Oct 08, 2026

Oct 07, 2026

Can Hormel Foods Tackle Input Costs With Pricing and Efficiency? - Zacks Investment Research

Oct 07, 2026

Oct 06, 2026

Medifast stock faces a smaller coach base after Q2 revenue beat - AD HOC NEWS

Oct 06, 2026

Can Medifast's Better Client Retention Support Revenue Stabilization? - Zacks Investment Research

Oct 06, 2026

Can Medifast's Better Client Retention Support Revenue Stabilization? - Yahoo Finance

Oct 06, 2026

Can Medifast's Better Client Retention Support Revenue Stabilization? - TradingView

Oct 06, 2026

Why Do You Keep Gaining Weight Back After Losing It - GlobeNewswire Inc.

Oct 06, 2026

Bank of America buys 87,118 Medifast shares for its portfolio - AD HOC NEWS

Oct 06, 2026

Oct 05, 2026

Medifast stock gets a new Bank of America stake - AD HOC NEWS

Oct 05, 2026

Oct 03, 2026

Bank of America Corp DE Purchases New Holdings in Medifast Inc $MED - marketbeat.com

Oct 03, 2026

Oct 02, 2026

Medifast director trust sells 19,089 shares. Medifast stock gains 1.67 percent - AD HOC NEWS

Oct 02, 2026

Don't Ignore The Insider Selling In Medifast - Simply Wall Street

Oct 02, 2026

Oct 01, 2026

Will Innovation and Digital Expansion Efforts Drive Clorox's Growth? - Zacks Investment Research

Oct 01, 2026

Here's Why Shares of BranchOut Food Surge 89% in a Year - Zacks Investment Research

Oct 01, 2026

Sep 30, 2026

Medifast (NYSE:MED) Stock: Insider Daniel Chard Sells 9,544 Shares - MarketBeat

Sep 30, 2026

Medifast (NYSE:MED) Stock: Insider Daniel Chard Sells 9,545 Shares - MarketBeat

Sep 30, 2026

Form 4 Medifast Inc For: 30 September By Investing.com - Investing.com South Africa

Sep 30, 2026

Medifast director Daniel Chard sells $226,288 in company shares - Investing.com

Sep 30, 2026

Form 4 Medifast Inc For: 30 September By Investing.com - Investing.com Canada

Sep 30, 2026

A preset trading plan covers Medifast (MED) director Chard's trust sales of 9,545 and 9,544 shares. - Stock Titan

Sep 30, 2026

Sep 29, 2026

Medifast (MED) officer Daniel Chard proposes selling 9,544 shares after a sale of 9,545 shares - Stock Titan

Sep 29, 2026

Hormel Foods Pricing Strategy: Can It Balance Value and Profitability? - Zacks Investment Research

Sep 29, 2026

Sep 28, 2026

Four stock-award lots make up Medifast (MED) officer Daniel Chard’s planned sale of 9,545 shares. - Stock Titan

Sep 28, 2026

Simile a MED

Medifast Inc (MED)

Profilo aziendale di Medifast Inc (MED)

Cap. di mercato

Reddito

Reddito netto

Flusso di cassa

EPS

Medifast Inc Azioni (MED) Upgrade e downgrade

Medifast Inc Azioni (MED) Dati Finanziari

Medifast Inc Azioni (MED) insider trading

Medifast Inc Borsa (MED) Ultime notizie

5 insightful analyst questions from Medifast’s Q3 earnings call - Yahoo Finance

Medifast Is Running The Same Playbook, And I Have The Same Concerns (NYSE:MED) - Seeking Alpha

Medifast Q3 Loss Narrower Than Expected as Coach Productivity Rises - Zacks Investment Research

Medifast Q3 Loss Narrower Than Expected as Coach Productivity Rises - TradingView

Form 144 MEDIFAST INC For: 27 October By Investing.com - Investing.com Nigeria

Form 144 MEDIFAST INC For: 27 October By Investing.com - Investing.com UK

Medifast Inc (MED) (Q3 2026) Earnings Call Highlights: Revenue Stabilizes Near $75 Million as ... - Yahoo Finance

Medifast, Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:MED) 2026-10-26 - Seeking Alpha

Medifast, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance

Medifast Q3 Revenue Falls 19.4% to $72 Million - grafa.com

What Medifast (MED) Said on Its Q3 Earnings Call - TradingView

Medifast Inc reports results for the quarter ended September 30 - Earnings Summary - TradingView

Medifast Q3 2026 Earnings Call Transcript - Benzinga

Medifast: Q3 Earnings Snapshot - KTVB

Medifast Reports $72 Million in Q3 Revenue and $17.5 Million Net Loss - TradingView

Medifast Announces Third Quarter 2026 Financial Results - Business Wire

Medifast Q3 Earnings on the Horizon: Key Insights for Investors - Zacks Investment Research

Medifast Q3 Earnings on the Horizon: Key Insights for Investors - Yahoo Finance

Zacks upgrades Medifast stock to Strong Buy ahead of October 26 results - AD HOC NEWS

Medifast (NYSE:MED) Short Interest Falls: What Does the Shift Reveal? - Kalkine Media

Medifast Inc (NYSE:MED) Sees Significant Decrease in Short Interest - MarketBeat

Quarterly results are scheduled before markets open Oct. 26, with Medifast's call at 8:30 a.m. - Stock Titan

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2026 - Business Wire

Best Momentum Stocks to Buy for October 14th - Zacks Investment Research

New Strong Buy Stocks for October 14th - Zacks Investment Research

Can Hormel Foods Keep Expanding Margins Despite Softer Retail Volumes? - Zacks Investment Research

Medifast (NYSE:MED) Shares Break Above 200-Day Moving Average - What's Next? - MarketBeat

Medifast presented Trilivy data and Medifast stock costs EUR 10.16 - AD HOC NEWS

Can Hormel Foods Tackle Input Costs With Pricing and Efficiency? - Zacks Investment Research

Medifast stock faces a smaller coach base after Q2 revenue beat - AD HOC NEWS

Can Medifast's Better Client Retention Support Revenue Stabilization? - Zacks Investment Research

Can Medifast's Better Client Retention Support Revenue Stabilization? - Yahoo Finance

Can Medifast's Better Client Retention Support Revenue Stabilization? - TradingView

Why Do You Keep Gaining Weight Back After Losing It - GlobeNewswire Inc.

Bank of America buys 87,118 Medifast shares for its portfolio - AD HOC NEWS

Medifast stock gets a new Bank of America stake - AD HOC NEWS

Bank of America Corp DE Purchases New Holdings in Medifast Inc $MED - marketbeat.com

Medifast director trust sells 19,089 shares. Medifast stock gains 1.67 percent - AD HOC NEWS

Don't Ignore The Insider Selling In Medifast - Simply Wall Street

Will Innovation and Digital Expansion Efforts Drive Clorox's Growth? - Zacks Investment Research

Here's Why Shares of BranchOut Food Surge 89% in a Year - Zacks Investment Research

Medifast (NYSE:MED) Stock: Insider Daniel Chard Sells 9,544 Shares - MarketBeat

Medifast (NYSE:MED) Stock: Insider Daniel Chard Sells 9,545 Shares - MarketBeat

Form 4 Medifast Inc For: 30 September By Investing.com - Investing.com South Africa

Medifast director Daniel Chard sells $226,288 in company shares - Investing.com

Form 4 Medifast Inc For: 30 September By Investing.com - Investing.com Canada

A preset trading plan covers Medifast (MED) director Chard's trust sales of 9,545 and 9,544 shares. - Stock Titan

Medifast (MED) officer Daniel Chard proposes selling 9,544 shares after a sale of 9,545 shares - Stock Titan

Hormel Foods Pricing Strategy: Can It Balance Value and Profitability? - Zacks Investment Research

Four stock-award lots make up Medifast (MED) officer Daniel Chard’s planned sale of 9,545 shares. - Stock Titan

Simile a MED